SEC Form 4 · accession 0001209191-18-031185
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — CEO and Chairman · Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 7:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | M | 15,000 | $5.49 | A | 115,446 | D | |
| Common Stock | May 15, 2018 | M | 10,000 | $10.81 | A | 125,446 | D | |
| Common StockF2 | May 15, 2018 | S | 21,106 | $33.69 | D | 104,340 | D | |
| Common StockF3 | May 15, 2018 | S | 3,894 | $34.34 | D | 100,446 | D | |
| Common StockF4 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF4 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $5.49 | May 15, 2018 | M | 15,000 | D | — | Dec 29, 2020 | Common Stock | 15,000 | 610 | D |
| Stock Option (Right to Buy)F7,F6 | $10.81 | May 15, 2018 | M | 10,000 | D | — | Jun 5, 2022 | Common Stock | 10,000 | 13,481 | D |
Explanation of responses
- F1The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $34.08, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.10 to $34.90, inclusive.
- F4Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.
- F5The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.
- F6The stock option vested as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.
- F7Reflects the transfer of stock options to purchase 23,481 shares of common stock previously held indirectly by the reporting person through LCK Investment LLC to the reporting person directly.